Doctor profile · Federal record
Dr. Santhosh Ambika, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology (Pathology) Physician · Reno, NV
- NPI 1174747323
- Accepts Medicare
- MIPS 91.6 / 100 · 2023
- 25 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5423 Reno Corporate Dr.
Reno, NV 895112250
(775) 329-0873
fax (775) 329-1026 - Mailing address
-
5423 Reno Corporate Dr
Reno, NV 895112250
Credentials & registration
- NPI registered
- April 2007 — 19 yrs on file
- Profile last updated
- May 22, 2019
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Nevada #16308
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1174747323. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
73,117
Distinct HCPCS
10
Medicare allowed
$2,443,533
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 20,600 | 25 | $54 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 13,680 | 16 | $48 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 8,160 | 12 | $0 | |
J9033 |
Injection, bendamustine hcl (treanda), 1 mg | 6,475 | 11 | $14 | |
J0185 |
Injection, aprepitant, 1 mg | 4,420 | 13 | $2 | |
J0897 |
Injection, denosumab, 1 mg | 3,000 | 19 | $23 | |
J0894 |
Injection, decitabine, 1 mg | 2,600 | 15 | $2 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,266 | 80 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,700 | 62 | $1 | |
J9041 |
Injection, bortezomib, 0.1 mg | 1,365 | 11 | $5 |
In context: peer comparison
Among 8 peers in Reno Hematology & Oncology Physician, average services per provider: 1,102. This provider delivers 66× the peer median.Open Payments
Industry payments received
All-time total
$22,511
Transactions
64
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 24 | $18,197.50 | |
| Taiho Oncology, INC. | 2 | $1,602.54 | |
| Daiichi Sankyo INC. | 6 | $1,350.11 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $110.11 | |
| Merck Sharp & Dohme LLC | 4 | $107.15 | |
| Genentech USA, INC. | 4 | $94.79 | |
| Pfizer INC. | 4 | $78.90 | |
| Sobi, INC | 2 | $77.16 | |
| TerSera Therapeutics LLC | 2 | $65.06 | |
| SpringWorks Therapeutics, INC. | 2 | $58.26 | |
| Deciphera Pharmaceuticals INC. | 2 | $55.07 | |
| Astellas Pharma US INC | 2 | $50.91 | |
| Mirati Therapeutics, INC. | 2 | $49.99 | |
| Array Biopharma INC | 2 | $49.96 | |
| Emd Serono, INC. | 2 | $49.88 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
678
Patients
167
Total drug cost
$2,766,384
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 103 | 36 | $3,272 |
| Hydroxyurea | Generic | 74 | 18 | $2,582 |
| Levothyroxine Sodium | Generic | 64 | 14 | $443 |
| Acyclovir | Generic | 51 | 16 | $790 |
| Brukinsa (Zanubrutinib) | Brand | 48 | 0 | $565,910 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 47 | 0 | $770,036 |
| Alendronate Sodium | Generic | 39 | 11 | $557 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 39 | 16 | $447 |
| Ibrance (Palbociclib) | Brand | 35 | 0 | $547,749 |
| Ondansetron Odt (Ondansetron) | Brand | 35 | 22 | $547 |
Hospital affiliations
Frequently asked questions
What is Dr. Santhosh Ambika's medical specialty?
Dr. Santhosh Ambika practices Hematology & Oncology Physician in Reno, NV.
Where does Dr. Santhosh Ambika practice?
Dr. Santhosh Ambika practices at 5423 Reno Corporate Dr., Reno, NV 895112250. Office phone: 7753290873.
What is Dr. Santhosh Ambika's NPI?
Dr. Santhosh Ambika's National Provider Identifier (NPI) is 1174747323, issued by NPPES.
Does Dr. Santhosh Ambika accept Medicare assignment?
Yes. Dr. Santhosh Ambika accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Santhosh Ambika commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138). Source: CMS Medicare Physician & Other Practitioners file.